Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients

Completed · Early Phase 1

Conditions studied: Bone Diseases, Endocrine, Nutritional and Metabolic Diseases

In brief

The overall objective of the study is to examine the changes within the gut microbiome after the supplementation of inulin and its effect on markers of mineral metabolism and bone turnover.

Key facts

Study ID

NCT02718885

Run by

University of Illinois at Urbana-Champaign

People needed

20

Starts

2016-05-01

Expected to finish

2018-07-01

Last updated by the study team

2018-08-02

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Receive HD therapy 3 days per week and for at least 3 months

You may not qualify if…

• Sustained hypercalcemia (>3months).
• Previous major gastrointestinal disease diagnosis (e.g., inflammatory bowel disease and celiac disease).
• Antibiotic treatment < 2 weeks prior the start of the study.

Where it is running

• University of Illinois at Urbana-Champaign — Urbana, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.